Skip to main content
SpringerLink
Log in

FAQ: HT and Other Conditions: Uterine Fibroids, Autoimmune disease, Hypothyroidism, and History of Breast Cancer

  • Chapter
  • First Online:
Hormone Therapy

  • 1447 Accesses

Abstract

Q.Are women with uterine fibroids appropriate candidates for HT?

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Bibliography

  1. Crandall CJ, Guan M, Laughlin GA. Increases in serum estrone sulfate level are associated with increased mammographic density during menopausal hormone therapy. Cancer Epidemiol Biomarkers Prev. 2008;17(7):1674–81.

    Article  PubMed  CAS  Google Scholar 

  2. Fournier A, Berrino F, Clavel-Chapelon F. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat. 2008;107(1):103–11.

    Article  PubMed  CAS  Google Scholar 

  3. Islander U, Jochems C, Lagerquist MK, et al. Estrogens in rheumatoid arthritis; the immune system and bone. Mol Cell Endocrinol. 2011;335:14–29.

    Article  PubMed  CAS  Google Scholar 

  4. King J, Harper Wynne C, Assersohn L, Jones A. Hormone replacement therapy and women with premature menopause—a cancer survivorship issue. Eur J Cancer. 2011;47:1623–32.

    Article  PubMed  CAS  Google Scholar 

  5. Schwartz E, Holtorf K. Hormone replacement therapy in the geriatric patient: current state of the evidence and questions for the future. Estrogen, progesterone, testosterone, and thyroid hormone augmentation in geriatric clinical practice: part 1. Clin Geriatr Med. 2011;27:541–59.

    Article  PubMed  Google Scholar 

  6. Sjoquist KM, Martyn J, Edmondson RJ, Friedlander ML. The role of hormonal therapy in gynecological cancers—current status and future directions. Int J Gynecol Cancer. 2011;21:1328–33.

    PubMed  Google Scholar 

  7. Ziva Cerne J, Novakovic S, Frkovic-Grazio S, et al. Estrogen metabolism genotypes, use of long-term hormone replacement therapy and risk of postmenopausal breast cancer. Oncol Rep. 2011;26(2):479–85.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Drexel Center for Women’s Health, Drexel University College of Medicine, Philadelphia, PA, USA

    Katherine Sherif MD, FACP

Authors
  1. Katherine Sherif MD, FACP
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Sherif, K. (2013). FAQ: HT and Other Conditions: Uterine Fibroids, Autoimmune disease, Hypothyroidism, and History of Breast Cancer. In: Hormone Therapy. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6268-2_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-6268-2_13

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-6267-5

  • Online ISBN: 978-1-4614-6268-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation